Portage Biotech's 15min chart shows RSI Overbought, KDJ Death Cross signals.

Based on the technical analysis of Portage Biotech's 15-minute chart, the Relative Strength Index (RSI) has reached an overbought level, while the KDJ indicator has formed a death cross at 09/03/2025 12:45. This indicates that the stock price has risen excessively and is no longer supported by fundamental values, suggesting a shift in momentum towards a decline and potential further decreases in stock price.

Title: AlphaTON Capital's Strategic Shift: TON Treasury Strategy and Nasdaq Listing

AlphaTON Capital Corp, formerly known as Portage Biotech, has announced a significant strategic transformation aimed at bridging traditional markets with the emerging blockchain ecosystem. The company has launched a $100 million TON treasury strategy, marking its entry into the TON blockchain ecosystem. The move includes a rebranding as ATON and a listing on Nasdaq under the new ticker.

AlphaTON Capital secured approximately $38.2 million through a private placement, issuing 6.7 million shares at $5.73 each. Additionally, the company secured a $35 million loan facility from BitGo Prime to fund its TON treasury strategy. This treasury strategy combines staking, validation, and ecosystem development within Telegram’s billion-user network.

The company’s new treasury strategy aims to leverage validator operations and staking rewards for consistent revenue. It plans to support decentralized applications, DeFi protocols, and TON-based gaming platforms, positioning itself to build long-term shareholder value through predictable revenue streams and large-scale adoption. Enzo Villani, incoming Executive Chairman and CIO, stated, "We are positioning our shareholders to participate in the next major phase of digital asset adoption."

Brittany Kaiser has been appointed as the new CEO of AlphaTON, bringing her blockchain leadership expertise to the company. Kaiser stated, "We are investing in a future where users own their data and digital assets." The company has also added several strategic advisors, including Anthony Scaramucci and Michael Terpin, and has partnered with notable firms like Animoca Brands and Crypto.com, further strengthening its position in the TON ecosystem.

The TON token saw a 2% increase following AlphaTON’s announcement. Despite a slight decline in the last week, the token surged by more than 5% after its listing on Robinhood. This move positions AlphaTON as the second public firm to enter Telegram’s blockchain ecosystem with a focus on Toncoin.

Portage Biotech had been primarily focused on clinical-stage biopharmaceuticals, but this strategic shift reflects a significant pivot towards the digital asset space. The company had been listed as PRTG on Nasdaq and had reported promising preclinical results for its cancer treatment drugs, PORT-7 and PORT-6. However, the latest move indicates a focus on digital assets and blockchain technology.

AlphaTON’s entry into the TON ecosystem is a bold move that could redefine its market presence and shareholder value. Investors should closely monitor the company’s progress in implementing its treasury strategy and its ability to generate consistent revenue through validator operations and staking rewards.

References

[1] https://blockonomi.com/alphaton-unveils-100m-ton-treasury-and-nasdaq-rebrand-to-aton/
[2] https://www.stocktitan.net/news/PRTG/